Welcome to Cora · $15 off your first month · use CORA15 at checkout→
24/7 Messaging SupportLegitScript-Certified100% OnlineUS-Licensed PharmaciesFree ShippingProvider Review in 24 HoursHSA/FSA Accepted24/7 Messaging SupportLegitScript-Certified100% OnlineUS-Licensed PharmaciesFree ShippingProvider Review in 24 HoursHSA/FSA Accepted
Pricing breakdown · October 2026

What does semaglutide actually cost in 2026?

Quick answer

As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, the current Wegovy® list price is about $1,349/month; list price (wholesale acquisition cost, WAC) is not a pharmacy cash-price quote. Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, WAC will be $675/month for Wegovy® 2.4 mg injection and 25 mg tablets, Ozempic® 0.5/1/2 mg and Rybelsus® 7/14 mg. The announced change does not affect direct-to-patient self-pay prices. As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

At a glance

Source Monthly cost What you get
Wegovy® list price (WAC); as of October 15, 2026 About $1,349/month currently; announced $675/month from January 1, 2027 As of October 15, 2026, the current Wegovy® list price is about $1,349/month; list price (wholesale acquisition cost, WAC) is not a pharmacy cash-price quote. Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, WAC will be $675/month for Wegovy® 2.4 mg injection and 25 mg tablets, Ozempic® 0.5/1/2 mg and Rybelsus® 7/14 mg. The announced change does not affect direct-to-patient self-pay prices. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
NovoCare® Wegovy® pen self-pay; as of October 15, 2026 $349/month (0.25–2.4 mg); $399/month (HD 7.2 mg); introductory $199/month for two eligible fills As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
NovoCare® Wegovy® pill self-pay; as of October 15, 2026 $149/month (1.5 mg); $199/month (4 mg); $299/month (9 or 25 mg) As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
Compounded semaglutide prescribed through Cora Health (Essential Plan, annual) $99/month ($1,188 billed upfront every 12 months) As of October 2026. Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
Compounded semaglutide prescribed through Cora Health (Essential Plan, monthly) $175/month ($175 billed monthly) As of October 2026. Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

Refund and cancellation policy. Manufacturer self-pay eligibility and restrictions apply; manufacturer prices verified October 15, 2026. Cora Health prices are as of October 2026. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms. Wegovy®, Ozempic®, Rybelsus® and NovoCare® are registered trademarks of Novo Nordisk A/S.

Brand-name semaglutide cost: Wegovy® and Ozempic®

As of October 15, 2026, the current Wegovy® list price is about $1,349/month; list price (wholesale acquisition cost, WAC) is not a pharmacy cash-price quote. Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, WAC will be $675/month for Wegovy® 2.4 mg injection and 25 mg tablets, Ozempic® 0.5/1/2 mg and Rybelsus® 7/14 mg. The announced change does not affect direct-to-patient self-pay prices.

As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program.

As of October 15, 2026, Wegovy® injection is approved, with diet and physical activity, for weight reduction in eligible adults and children aged 12 and older with obesity, cardiovascular risk reduction in eligible adults, and treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults under accelerated approval. Wegovy® tablets are approved for weight reduction and cardiovascular risk reduction in eligible adults. Ozempic® is approved for type 2 diabetes, including glycemic control and cardiovascular and kidney risk reduction in eligible adults with type 2 diabetes; it is not approved for weight management.

NovoCare® Wegovy® price guide and offer terms · Novo Nordisk’s February 24, 2026 list-price announcement · Wegovy® prescribing information · Ozempic® prescribing information. Wegovy®, Ozempic®, Rybelsus® and NovoCare® are registered trademarks of Novo Nordisk A/S.

Compounded semaglutide cost

As of October 2026, compounded semaglutide is prepared under a patient-specific prescription. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. The FDA does not review compounded medications for safety, effectiveness or quality before marketing.

As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

Cora Essential Plan tier Monthly Billed Notes
Annual (12 months) $99/mo $1,188 every 12 months As of October 2026, Essential Plan. Billed upfront every 12 months; renews automatically. Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
Semi-Annual (6 months) $120/mo $720 every 6 months As of October 2026, Essential Plan. Billed upfront every 6 months; renews automatically. Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
Quarterly (3 months) $145/mo $435 every 3 months As of October 2026, Essential Plan. Billed upfront every 3 months; renews automatically. Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.
Monthly $175/mo $175 billed monthly As of October 2026, Essential Plan. Billed monthly; renews automatically until you cancel. Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

As of October 2026. Licensed providers at Wasef Health, PC make prescribing decisions. Prescriptions are fulfilled by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx. Cora Health does not prescribe or compound medication. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

Does the price of compounded semaglutide change with the dose?

On Cora Health's standard plans, no. The standard plan charges one price per billing term for compounded semaglutide, and that price is the same at every dose your provider prescribes on that plan — including when your dose increases partway through a prepaid plan. Cora's microdose plans are separate, with their own intake, one fixed weekly dose and their own prices; a higher dose is not part of a microdose plan. On the standard plan, compounded semaglutide is $99/month on the annual plan, $120/month semi-annual, $145/month quarterly, or $175/month month to month; the table above shows what each term bills. Each price includes the provider consultation, the medication, expedited shipping and ongoing monitoring. Your dose is set by a licensed provider at Wasef Health, PC — Cora Health does not prescribe. Medication is compounded by US-licensed 503A pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx. Plans renew automatically until you cancel, and on prepaid plans the per-month rate applies to the completed term — see our refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products.

Prices verified against Cora's billing system on November 2, 2026.

Compounded semaglutide prices across telehealth providers (Cora Health dataset, July 2026 edition)

Cora Health pricing dataset, July 2026 edition: effective monthly competitor costs include any recorded membership fee and may have changed since collection. Selected providers from the dataset are shown; the public dataset lists every row. “All-inclusive?” here means no separate membership fee in the dataset; verify consultation, laboratory, shipping and other charges directly. “—” means no matching dataset row for that term, not that a provider cannot offer it. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Cora Health’s own terms below are current as of October 2026; cancellation policy.

Provider Annual Semi-Annual Quarterly Monthly All-inclusive? Pharmacy named?
Cora Health Essential Plan (standard plan; microdose plans priced separately) — October 2026 (this site) As of October 2026, Essential Plan: $99/mo ($1,188 billed upfront every 12 months). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. As of October 2026, Essential Plan: $120/mo ($720 billed upfront every 6 months). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. As of October 2026, Essential Plan: $145/mo ($435 billed upfront every 3 months). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. As of October 2026, Essential Plan: $175/mo ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Yes US-licensed 503A compounding pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx
Belle Health — Cora Health pricing dataset, July 2026 edition — $119/mo ($714 total over 6 months) $135/mo ($405 total over 3 months) $199/mo Yes Yes (dataset)
Eden (TryEden) — Cora Health pricing dataset, July 2026 edition — — — $198/mo No (membership) No (dataset)
Henry Meds — compounded semaglutide injections; program prices checked October 16, 2026 — — — $297/mo (1-month injection program) Yes No (dataset)
Ivim Health — Cora Health pricing dataset, July 2026 edition — — — $149.99/mo No (membership) No (dataset)
Lemonaid Health — Cora Health pricing dataset, July 2026 edition — — $298/mo ($894 total over 3 months) $348/mo No (membership) No (dataset)
Joi + Blokes — Cora Health pricing dataset, July 2026 edition — — $199/mo ($597 total over 3 months) — Yes No (dataset)
Pomegranate Health — Cora Health pricing dataset, July 2026 edition — — — $119/mo Yes Yes (dataset)

Competitor figures: Cora Health pricing dataset, July 2026 edition; prices may have changed since collection. Multi-month totals are effective monthly cost × the dataset term, including recorded membership; they do not establish when a competitor bills each charge. Verify billing timing directly. Public dataset and sources (CC-BY-4.0). Henry Meds program prices: henrymeds.com/legal/programs (last updated December 3, 2025; checked October 16, 2026). Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

What is included in the price, and what to compare

As of October 2026, compare the total checkout amount, required membership, consultation, laboratory services, shipping, follow-ups, dose conditions and prepaid term. Ask for a written breakdown before purchasing. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

As of October 2026, the Cora Health Essential Plan includes the licensed-provider consultation, compounded semaglutide, US-licensed 503A pharmacy fulfillment, expedited shipping and ongoing monitoring. There is no separate membership, follow-up or dose-escalation fee on the Essential Plan. Plans renew automatically until you cancel. Prices may change. A licensed provider decides eligibility. Cancellation policy. Compounded medications are not FDA-approved.

Semaglutide and insurance coverage

As of October 15, 2026, eligible commercially insured patients may pay as little as $25/month for Wegovy® with the NovoCare® savings offer, subject to maximum savings of $100/month. Government beneficiaries are excluded from this commercial-insurance offer. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Confirm coverage, deductible and prior authorization with your insurer.

As of October 2026, Cora Health does not bill insurance. Discuss reimbursement questions directly with your insurer. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

Brand-name and compounded semaglutide: payment options and prices (as of October 2026)

As of October 2026, brand-name and compounded products have different approval status, eligibility and payment conditions. Discuss the appropriate prescription with a licensed provider. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

  • As of October 15, 2026, eligible commercially insured patients may pay as little as $25/month for Wegovy® with the NovoCare® savings offer, subject to maximum savings of $100/month. Government beneficiaries are excluded from this commercial-insurance offer. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Confirm coverage, deductible and prior authorization with your insurer.
  • As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program.
  • As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.
  • Reference only (manufacturer list price; what you pay depends on your insurance and pharmacy): As of October 15, 2026, the current Wegovy® list price is about $1,349/month; list price (wholesale acquisition cost, WAC) is not a pharmacy cash-price quote. Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, WAC will be $675/month for Wegovy® 2.4 mg injection and 25 mg tablets, Ozempic® 0.5/1/2 mg and Rybelsus® 7/14 mg. The announced change does not affect direct-to-patient self-pay prices.

Frequently asked questions about semaglutide cost

How much does semaglutide cost without insurance in 2026?

As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, the current Wegovy® list price is about $1,349/month; list price (wholesale acquisition cost, WAC) is not a pharmacy cash-price quote. Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, WAC will be $675/month for Wegovy® 2.4 mg injection and 25 mg tablets, Ozempic® 0.5/1/2 mg and Rybelsus® 7/14 mg. The announced change does not affect direct-to-patient self-pay prices. As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

What do Wegovy® savings offers, NovoCare® self-pay and compounded semaglutide plans cost in 2026?

As of October 15, 2026, eligible commercially insured patients may pay as little as $25/month for Wegovy® with the NovoCare® savings offer, subject to maximum savings of $100/month. Government beneficiaries are excluded from this commercial-insurance offer. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Confirm coverage, deductible and prior authorization with your insurer. As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms. Brand-name and compounded products have different approval status. A licensed provider should help determine an appropriate medication.

How do compounded semaglutide and brand-name Wegovy®/Ozempic® prices differ?

As of October 2026, brand-name and compounded products have different regulatory and production structures. Patient-specific compounded semaglutide is prepared by a US-licensed 503A compounding pharmacy under a licensed provider’s prescription. A price difference does not establish equivalent safety, quality or effectiveness. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. The FDA does not review compounded medications for safety, effectiveness or quality before marketing. Compare prices in the Cora Health pricing dataset (July 2026 edition) table on this page; competitor prices may have changed since collection.

Is Wegovy® or Ozempic® covered by insurance?

As of October 15, 2026, eligible commercially insured patients may pay as little as $25/month for Wegovy® with the NovoCare® savings offer, subject to maximum savings of $100/month. Government beneficiaries are excluded from this commercial-insurance offer. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Confirm coverage, deductible and prior authorization with your insurer. As of October 15, 2026, Ozempic® is approved for type 2 diabetes, not weight management. Coverage depends on the prescribed product, indication and insurance plan. As of October 2026, Cora Health does not bill insurance; confirm reimbursement questions directly with your insurer. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

How much do brand-name and compounded semaglutide products cost per month in 2026?

The applicable price depends on prescribed dose, insurance and billing term; no single price applies to everyone. As of October 15, 2026, eligible commercially insured patients may pay as little as $25/month for Wegovy® with the NovoCare® savings offer, subject to maximum savings of $100/month. Government beneficiaries are excluded from this commercial-insurance offer. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. Confirm coverage, deductible and prior authorization with your insurer. As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

How much does Wegovy® cost without insurance?

As of October 15, 2026, NovoCare® Wegovy® pen self-pay prices are $349/month at 0.25, 0.5, 1, 1.7 or 2.4 mg and $399/month for Wegovy® HD 7.2 mg. New patients pay $199/month for the first two monthly fills of 0.25 mg or 0.5 mg under the offer through December 31, 2026, then the applicable standard price. One month is one box of four weekly pens (28 days). Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, NovoCare® Wegovy® pill self-pay prices are $149/month at 1.5 mg, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is 30 tablets. These dose-specific prices are not a choice of interchangeable doses; a licensed provider determines the prescribed dose. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program. As of October 15, 2026, the current Wegovy® list price is about $1,349/month; list price (wholesale acquisition cost, WAC) is not a pharmacy cash-price quote. Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, WAC will be $675/month for Wegovy® 2.4 mg injection and 25 mg tablets, Ozempic® 0.5/1/2 mg and Rybelsus® 7/14 mg. The announced change does not affect direct-to-patient self-pay prices.

What is the announced 2027 list price for Ozempic®?

Novo Nordisk announced on February 24, 2026 that, effective January 1, 2027, the list price (WAC) of Ozempic® 0.5 mg, 1 mg and 2 mg will be $675 per month; Novo Nordisk says self-pay prices are not affected. Ozempic® is approved for type 2 diabetes, not weight management. Confirm your actual out-of-pocket price with your pharmacy and insurer.

Can licensed providers prescribe brand-name or compounded semaglutide online?

As of October 2026, licensed telehealth providers may prescribe FDA-approved Wegovy® or Ozempic® when clinically appropriate. Ozempic® is not approved for weight management. Through Cora Health, independent licensed providers at Wasef Health, PC decide eligibility for patient-specific compounded semaglutide prescriptions. Licensed providers at Wasef Health, PC make prescribing decisions. Prescriptions are fulfilled by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx. Cora Health does not prescribe or compound medication. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®.

How do yearly costs compare: Wegovy® pens at NovoCare® self-pay prices versus compounded semaglutide on the Cora Health Essential Plan?

As of October 2026, on the Cora Health Essential Plan, compounded semaglutide prescribed through Cora Health is $99/month ($1,188 billed upfront every 12 months), $120/month ($720 billed upfront every 6 months), $145/month ($435 billed upfront every 3 months), or $175/month ($175 billed monthly). Plans renew automatically until you cancel. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Refund and cancellation policy. Essential Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Wegovy®/Ozempic®. Other telehealth providers also offer compounded semaglutide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms. As of October 15, 2026, NovoCare® defines a Wegovy® pen month as four weekly pens (28 days), so a 52-week year requires 13 fills: 13 × $349 = $4,537 for the 0.25–2.4 mg pens, or 13 × $399 = $5,187 for Wegovy® HD 7.2 mg at standard self-pay rates. Eligibility and restrictions apply. These illustrations assume unchanged pricing, exclude introductory savings and are not dosing schedules or annual-plan offers. A licensed provider determines the appropriate product and dose.

See if compounded semaglutide is right for you

As of October 2026, Cora Health connects patients with independent licensed providers through an online assessment. A licensed provider reviews your health profile and — when clinically appropriate — writes a patient-specific prescription. Compounded semaglutide is not FDA-approved. Individual results vary.

See Cora Health Essential Plan

Cora Health does not prescribe medication. Pharmacy partners · Safety · FAQs